BeOne Medicines
Richard O'Keeffe is the Head of Global Quality at BeiGene since May 2023, responsible for GxP compliance, QA, and QC while developing a world-class quality organization. Previously, Richard O'Keeffe held the role of Vice President - Quality (R&D) at Amgen from June 2006 to May 2023, overseeing the R&D function's quality management, including GCP, GLP, and GPvP. Richard O'Keeffe also served as the Quality Site Head and Executive Director at Amgen's Thousand Oaks campus, managing a large team and ensuring quality in clinical and commercial manufacturing. Additional roles at Amgen included Head of International & Distribution Quality and Executive Director for Asia-Pacific Regional Quality. Earlier career experiences include positions at Schering-Plough Research Institute and Schering Pharmaceuticals, focusing on quality assurance and operational management. Richard O'Keeffe holds a BSc in Science from University College Cork, earned between 1986 and 1990.
This person is not in any teams
This person is not in any offices
BeOne Medicines
34 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.